Ann: DyeVert featured at the SCAI 2020 Scientific Session, page-19

First 19 Last

Share
Profile

Follow
livrepr8

459 Posts.

34

20/06/20

19:06

Post #: 45346224
Share

Originally posted by peto2810: ↑

Gazza the definition to me is also a little unclear in context to the study (refer below) however absolute
is a defined value or result and I would take relative
as being in context to previous records or statistics.

The announcement is as interesting as it is exciting. 2 case studies from 2 hospitals, one refered directly in the announcement and with the other case study having 1789 patients out of 1956 studied being a large sample set and both during an approximate period Q1 2018 to Q3 2019. (refer below)

Some google numbers to go by:
-Cardiac Catheter Labs USA 2119 (IMV census 2014)
- >1 million diagnostic cardiac catheterizations
(excluding percutaneous coronary
intervention–only procedures) performed in the USA (CHEST 2018)

Patients who would be in consideration for Dyevert Contrast Dye monitoring would depend on their risk score and general health eg. Pre existing kidney issues, diabetes etc. But from the announced studies what % of those >1m treatments can we approximate require DyeVert intervention?

However it is looked at, there is a clear need for the device to deliver better patient health and outcomes, clearly from the studies the reporting timeline is slow however continued appraisals and hospital procedure, peer reviews will see uptake continue to climb and potentially greater with EU markets via GE should a distribution deal be concluded in the coming months.

All imo DYOR.

Keep well cheers Paul

Expand

Very good read about how effective Dyevert system is in cathlab setting.
https://www.cathlabdigest.com/content/incorporating-dyevert-system-focused-protocols-hard-stop-contrast-induced-acute-kidney-injury
The GE deal once finalised will be game changer for the company,

IMO

OSP Price at posting: 1.1¢ Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Drilling at Lady Ilse suggests gold-copper porphyry, grows footprint for Magmatic

OPL

Opyl forms JV with UK and US consortium to bring products to the world

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition